A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patie...
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
About this item
Full title
Author / Creator
Fukada, Ippei , Ito, Yoshinori , Kondo, Naoto , Ohtani, Shoichiro , Hattori, Masaya , Tokunaga, Eriko , Matsunami, Nobuki , Mashino, Kohjiro , Kosaka, Taijiro , Tanabe, Masahiko , Yotsumoto, Daisuke , Yamanouchi, Kosho , Sawaki, Masataka , Kashiwaba, Masahiro , Kawabata, Hidetaka , Kuroi, Katsumasa , Morita, Satoshi , Ohno, Shinji , Toi, Masakazu and Masuda, Norikazu
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose
The sequence of taxanes (T) followed by anthracyclines (A) as neoadjuvant chemotherapy has been the standard of care for almost 20 years for locally advanced breast cancer (LABC). Sequential administration of eribulin (E) following A/T could provide a greater response rate for women with LABC.
Methods
In this single-arm, multicente...
Alternative Titles
Full title
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
Authors, Artists and Contributors
Author / Creator
Ito, Yoshinori
Kondo, Naoto
Ohtani, Shoichiro
Hattori, Masaya
Tokunaga, Eriko
Matsunami, Nobuki
Mashino, Kohjiro
Kosaka, Taijiro
Tanabe, Masahiko
Yotsumoto, Daisuke
Yamanouchi, Kosho
Sawaki, Masataka
Kashiwaba, Masahiro
Kawabata, Hidetaka
Kuroi, Katsumasa
Morita, Satoshi
Ohno, Shinji
Toi, Masakazu
Masuda, Norikazu
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8558278
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8558278
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-021-06396-0
